Advertisement
Screener

CERENOME, INC. (CNSY) Revenue from Contract with Customer, Excluding Assessed Tax

0.9 / 5 stars · 12/68 Roast Me

CERENOME, INC. Revenue from Contract with Customer, Excluding Assessed Tax

CERENOME, INC. (CNSY) reported Revenue from Contract with Customer, Excluding Assessed Tax of $703.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.

Discontinued › Income Statement › Revenue

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2019-05-14

  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-03-31 was $703.00K, a 3.83% decline year-over-year.
  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2018-12-31 was $1.42M, a 114.80% increase year-over-year.
  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2018-09-30 was $858.00K, a 83.73% increase year-over-year.
  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2018-03-31 was $731.00K.
  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for fiscal 2018 was $3.67M, a 36.52% increase from fiscal 2017.
  • CERENOME, INC. revenue from contract with customer, excluding assessed tax for fiscal 2017 was $2.69M.
Period endRevenue from Contract with Customer, Excluding Assessed Tax 3 monthRevenue from Contract with Customer, Excluding Assessed Tax 6 monthRevenue from Contract with Customer, Excluding Assessed Tax 9 monthRevenue from Contract with Customer, Excluding Assessed Tax 12 month
2019-03-31$703.00K
10-Q · filed 2019-05-14
$2.13M
derived: sum of 2 quarters · filed 2019-05-14
$2.98M
derived: sum of 3 quarters · filed 2019-05-14
2018-12-31$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$2.28M
derived: sum of 2 quarters · filed 2019-03-29
$3.67M
10-K · filed 2019-03-29
2018-09-30$858.00K
10-Q · filed 2018-11-14
$2.25M
10-Q · filed 2018-11-14
2018-03-31$731.00K
10-Q · filed 2019-05-14
$1.39M
derived: sum of 2 quarters · filed 2019-05-14
$1.86M
derived: sum of 3 quarters · filed 2019-05-14
2017-12-31$662.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$1.13M
derived: sum of 2 quarters · filed 2019-03-29
$2.69M
10-K · filed 2019-03-29
2017-09-30$467.00K
10-Q · filed 2018-11-14
$2.03M
10-Q · filed 2018-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01
Modular Medical, Inc. (MODD)United States$0.018B-0.88
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
FEMASYS INC (FEMY)United States$0.020B-1.07
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
HeartBeam, Inc. (BEAT)United States$0.022B-2.08